NumFin

ZhuZhou QianJin Pharmaceutical Co.,Ltd

Symboli: 600479.SS

SHH

10.91

CNY

Markkinahinta tänään

  • 17.9517

    P/E-suhde

  • 0.4616

    PEG-suhde

  • 4.56B

    MRK Cap

  • 0.03%

    DIV Tuotto

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479-SS) Tilinpäätöstiedotteet

Download
VuosittainenNeljännesvuosittain
LineaarinenLog
Kaaviossa näet oletusarvot ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS). Yrityksen liikevaihto näyttää NaN M keskiarvon, joka on NaN % gowth. Koko jakson keskimääräinen bruttovoitto on NaN M, joka on NaN %. Keskimääräinen bruttovoittosuhde on NaN %. Yrityksen viime vuoden tuloksen nettotuloksen kasvu on NaN %, joka on NaN % % keskimäärin koko yrityksen historian aikana.,

VuosittainenNeljännesvuosittain
10Y20Y30Y40Y

Tase

ZhuZhou QianJin Pharmaceutical Co.,Ltd verotukselliseen kehitykseen sukeltamalla havaitsemme keskimääräisen varallisuuden kasvun. Tämä korko on mielenkiintoisesti , mikä heijastaa sekä yrityksen huippuja että matalimpia lukemia. Neljännesvuosittaisessa vertailussa tämä luku on . Kun tarkastellaan viime vuotta taaksepäin, kokonaisvarojen muutos on NaN. Osakkeenomistajien arvo, jota kuvaa osakepääoman kokonaismäärä, arvostetaan NaN raportointivaluutassa. Tämän näkökohdan vuosittainen muutos on NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

balance-sheet.row.cash-and-short-term-investments

01997.91731.71369.7
1407.6
1378
1100.2
690.3
736.2
544.3
297
205.3
243.2
217.7
334.9
416.9
507.4
527.4
435.8
410.4
383.6
71.3
72.9
93.4

balance-sheet.row.short-term-investments

0-45.7491.7736.8
652.3
-39.6
109.1
182.2
7.8
31.1
69.6
22.1
92.5
98.5
60.3
232
0.2
130
35
6
6.1
0
0
0.2

balance-sheet.row.net-receivables

0967983.9921.6
1164.8
1078.8
972.4
1043
951.2
843.5
876.3
743
610.6
558.1
307.8
260.4
196.8
105.9
113.7
143.4
160.4
113.9
82.8
97.7

balance-sheet.row.inventory

0534.1599547.8
496.8
469.5
440.9
376.3
358.5
272.3
243.2
222.5
195.3
117
126.5
98.8
96.5
82.9
87.3
75.1
84.1
84.9
71
77.5

balance-sheet.row.other-current-assets

015.4198.978.1
120.2
29
82.9
319.7
87.2
267.7
27
5.6
6.7
-29.7
-12.6
-9.8
-12.1
-4.2
-7.1
-8.7
-13.2
-11.6
-13.5
-19.4

balance-sheet.row.total-current-assets

03514.53513.52917.3
3189.3
2955.3
2596.3
2429.2
2133
1927.8
1443.6
1176.4
1055.8
863.1
756.5
766.3
788.6
711.9
629.7
620.1
614.8
258.5
213.1
249.1

balance-sheet.row.property-plant-equipment-net

0589.9622.8630.2
491
478.7
499.8
529.2
565.4
491.4
415.2
396.8
334.6
309.8
285.4
286.7
193.2
153.4
154.6
160
163
150.2
134.7
77.3

balance-sheet.row.goodwill

014.114.114.1
14.1
14.1
14.1
14.1
14.1
14.1
14.1
14.1
8.7
8.7
8.7
8.7
8.7
8.7
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0238.3221.8219.6
216.4
255.2
285.8
241.2
259.8
260.4
247.3
252.8
199.5
45.3
46.5
47.7
47.1
20.2
20.2
4.4
4.6
4.6
4.5
4.6

balance-sheet.row.goodwill-and-intangible-assets

0252.3235.9233.7
230.5
269.3
299.9
255.3
273.9
274.5
261.4
266.9
208.2
54
55.2
56.5
55.8
28.9
20.2
4.4
4.6
4.6
4.5
4.6

balance-sheet.row.long-term-investments

0293.3-304.1-546.1
-462
103
-63.7
-136.8
37.6
4.3
-33.2
14.2
-57.2
-57
-40.5
-86.9
13.4
54
-16.4
3.9
0.5
0
0
0.4

balance-sheet.row.tax-assets

022.76.64.1
4.2
4.2
4.6
6.9
4
3.4
2.5
2.7
1.3
2.1
0.9
0.5
0.5
1.4
0
0
0
0
0
1.3

balance-sheet.row.other-non-current-assets

04.2547.3821
775.7
1.7
135.7
203
18.2
41.9
139.5
31.2
102.4
109.7
71
242.8
7.9
135.6
40.7
9.8
9.7
7.9
7.6
0

balance-sheet.row.total-non-current-assets

01162.41108.51143
1039.4
856.9
876.2
857.6
899.1
815.4
785.4
711.9
589.4
418.6
371.9
499.5
270.8
373.3
199
178.1
177.7
162.8
146.8
83.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

04676.946224060.2
4228.7
3812.2
3472.5
3286.9
3032.1
2743.2
2228.9
1888.3
1645.2
1281.7
1128.5
1265.8
1059.4
1085.3
828.7
798.2
792.5
421.3
359.9
332.8

balance-sheet.row.account-payables

0647.5780.9511.7
623
529.1
485.8
469.5
446
317
369.4
168.9
86.1
80.2
80.7
109
91.7
82
81
56.1
69.5
74.6
49.1
77.3

balance-sheet.row.short-term-debt

078.279.588.6
135.9
1.9
1
1
0.5
3.1
61
87
115.9
0
0
131
0
0
0
0
12
33.1
32.8
1.5

balance-sheet.row.tax-payables

070.672.535.6
45.2
41
61.3
67.5
32.9
23.1
41.6
28.4
28.4
34.3
10
15.2
26.6
23.7
23.2
11.3
11.6
18.9
17.1
12.9

balance-sheet.row.long-term-debt-total

038.544.860.3
19.5
20.5
26.7
37.3
47.3
54
32
5.2
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
8.7

Deferred Revenue Non Current

03844.451.3
51.8
42.8
44.4
51.5
50.2
52.9
41.6
44.5
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

069.1705.675.5
84.9
192.3
407.8
130.1
165.4
149.6
125
97.9
76.8
181.3
81.5
19.5
89.4
83.6
85.5
144.7
1.9
5.5
1.6
0.7

balance-sheet.row.total-non-current-liabilities

0108.3108.5131.9
89
81.5
86.6
111.3
111.2
117.6
84.3
55.3
30
26.6
26.5
2.6
2.6
23.7
2.6
2.6
3
3.4
3.4
11.5

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

031.532.844.8
42.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

01650.11805.71360.3
1466.7
1182.6
1042.5
1045.7
948.2
779.2
843.2
683.9
581.2
288.1
188.6
314.5
183.7
189.3
169.1
203.4
148.4
188.2
174.3
182.8

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0428.9429.8418.5
418.5
418.5
418.5
348.8
348.8
348.8
304.8
304.8
304.8
304.8
304.8
217.7
181.4
151.2
126
84
56
38
38
38

balance-sheet.row.retained-earnings

01142.5970.8930.7
1047.2
959.4
826.1
694.2
568.4
481.4
456.1
414.1
377.7
328.3
328.2
356.9
295.8
260.5
115.5
60.7
122.1
114.1
71.9
57.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

0280.8275.3298.1
298.1
297.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0537.5540.3503
503
503
784.2
834.4
828.5
816.7
360.6
289.3
283.5
275.2
268.6
349.4
374.2
463
399
433.8
452.5
64.8
56
40.1

balance-sheet.row.total-stockholders-equity

02389.72216.22150.4
2266.8
2178.1
2028.8
1877.4
1745.7
1646.8
1121.5
1008.2
966
908.3
901.6
924
851.4
874.6
640.6
578.5
630.6
216.9
165.8
135.4

balance-sheet.row.total-liabilities-and-stockholders-equity

04676.946224060.2
4228.7
3812.2
3472.5
3286.9
3032.1
2743.2
2228.9
1888.3
1645.2
1281.7
1128.5
1265.8
1059.4
1085.3
828.7
798.2
792.5
421.3
359.9
332.8

balance-sheet.row.minority-interest

0637.1600.1549.5
495.2
451.5
401.1
363.8
338.2
317.2
264.3
196.2
98
85.3
38.2
27.3
24.3
21.3
19
16.4
13.5
16.1
19.7
14.5

balance-sheet.row.total-equity

03026.82816.32699.9
2762
2629.6
2430
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0247.6187.6190.8
190.3
63.4
45.3
45.3
45.3
35.3
36.3
36.3
35.3
41.6
19.8
145.1
13.6
184
18.6
10
6.5
6.5
5.5
0.5

balance-sheet.row.total-debt

0116.7124.2148.9
155.4
22.4
27.7
38.3
47.8
57.1
93
87
115.9
0.7
0.7
131
0.7
0.7
0.7
0.7
12
33.1
32.8
1.5

balance-sheet.row.net-debt

0-1881.2-1115.7-484
-600
-1355.5
-963.4
-469.8
-680.6
-456.1
-134.4
-96.2
-34.8
-118.5
-274
-53.9
-506.6
-396.7
-400.1
-403.7
-365.5
-38.2
-40.1
-91.7

Kassavirtalaskelma

ZhuZhou QianJin Pharmaceutical Co.,Ltd taloudessa on tapahtunut huomattava muutos vapaan kassavirran määrässä viimeisen ajanjakson aikana, ja se on muuttunut NaN suuntaan. Yhtiö on hiljattain laajentanut osakepääomaansa laskemalla liikkeeseen NaN, mikä merkitsee NaN eroa edelliseen vuoteen verrattuna. Yhtiön investointitoiminnasta aiheutui nettokassan käyttöä, joka oli NaN raportointivaluutassa. Tämä on NaN siirtymä edellisestä vuodesta. Samana ajanjaksona yhtiö kirjasi NaN, NaN ja NaN, jotka ovat merkittäviä yrityksen investointi-ja takaisinmaksustrategioiden ymmärtämisen kannalta. Yhtiön rahoitustoiminta johti siihen, että nettokassan käyttö oli NaN, ja ero edellisvuoteen oli {{year_over_year_net_cash_from_financing_activities_change_percentage}}. Lisäksi yhtiö osoitti NaN osingonjakoon osakkeenomistajilleen. Samaan aikaan se toteutti myös muita rahoitusmanöövereitä, joihin viitataan nimellä {{other-financing-activities}}, jotka myös vaikuttivat merkittävästi sen kassavirtaan kyseisenä ajanjaksona. Nämä osatekijät muodostavat yhdessä kattavan kuvan yrityksen taloudellisesta tilanteesta ja strategisesta lähestymistavasta kassavirran hallintaan.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002

cash-flows.row.net-income

0395388.3374.7
360.2
352.1
302.6
246.7
173.4
88.3
117.7
128.8
130.9
94.8
97.6
136.9
134.5
176.6
75
61.7
46.6
48.4
38.9

cash-flows.row.depreciation-and-amortization

0103.795.685.9
60.9
61.1
61.8
62.7
50.2
50.4
48.5
48.3
40
38.3
36
25.2
21.8
20.9
24.3
23.3
22
18.3
13.1

cash-flows.row.deferred-income-tax

0-2.8-3.62.7
1.4
-0.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

02.83.6-2.7
-1.4
0.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-81.7246.965.8
129.5
-233
29.3
-11.8
-81.8
-73.8
15.1
-49.5
40.4
-122.7
-81.4
-68.9
-88.6
2.4
47.2
-1.1
-46.4
-19.4
-45.6

cash-flows.row.account-receivables

0-8.7-163.7275.9
27.2
-362.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

062.3-51.2-52.4
-27.3
-29.1
-64.7
-17.9
-85.5
-29.9
-22.4
-19.8
-78.4
9.6
-27.7
-2
-13.2
3.7
1.7
8.3
1
-13.8
3.1

cash-flows.row.account-payables

0-132.5465.4-160.4
128.2
159.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-2.8-3.62.7
1.4
-0.9
94
6.1
3.8
-44
37.4
-29.6
118.8
-132.3
-53.7
-66.8
-75.4
-1.3
45.5
-9.4
-47.4
-5.6
-48.7

cash-flows.row.other-non-cash-items

026.12.7-40.9
-8.2
-24.7
-10.2
-14.1
-0.9
2.6
2.1
10.1
-13.6
12.2
-13
-19.7
-30.4
-120.6
-26.3
-7.5
-3.8
3.6
-0.3

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-44-34.4-71.9
-97.2
-40.6
-46.4
-57.3
-81.5
-84.5
-66
-84.3
-256.3
-63.9
-58.4
-123.3
-95.3
-22.5
-21.4
-16.7
-56.5
-34
-59.2

cash-flows.row.acquisitions-net

000.230.8
103.6
73
0
13
0.7
85
1.2
-21.4
0.6
1.3
5.8
0.8
0.3
0.8
2.1
0.6
1
0.1
0.2

cash-flows.row.purchases-of-investments

0-402-2102-1570
-2641
-285
-904
-1403.9
-1001.7
-769.6
-405
-135.1
-235.4
-891.1
-565.5
-1545.8
-1482
-576.3
-855.2
-1103.4
-225.3
-1
-5

cash-flows.row.sales-maturities-of-investments

01031.22258.41567.7
1770.3
469.5
1222.9
1006.1
1197.1
605.1
357.6
207.4
266.3
820.6
889.9
1194
1728.4
549.6
845.8
1107.5
219.4
0.5
0.3

cash-flows.row.other-investing-activites

00.100
-97.2
-40.6
2.5
24.3
5.9
-84.5
0.4
0.1
0
-3.9
1.6
2.8
2.8
3.1
2.4
1.8
3.7
2
1.6

cash-flows.row.net-cash-used-for-investing-activites

0585.3122.1-43.3
-961.5
176.3
275
-417.8
120.6
-248.5
-111.8
-33.3
-224.7
-137
273.3
-471.5
154.1
-45.3
-26.3
-10.3
-57.8
-32.5
-62.2

cash-flows.row.debt-repayment

0-50.7-15-127.6
-19.1
-6.2
-10.6
-9.5
-9.3
-105
-147
-180.9
-7.5
-20
-605
-4937
0
-550
-700
-12
-333.7
-39.7
-15.3

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-147.9-248.6-429.5
-209.3
-167.1
-105
-71.4
-54.4
-66.7
-60.7
-79.9
-61.3
-76.2
-108.9
-59.5
-79.6
-36.4
-96
-28.2
-32.1
-22
-7.7

cash-flows.row.other-financing-activites

0-13.1-0.536.5
124.2
-7.4
-9.1
-12.7
-1.2
620
154.9
180.8
125
55.2
497.8
5065.6
-1.9
548.9
698.6
0.9
711.3
41.7
58.8

cash-flows.row.net-cash-used-provided-by-financing-activities

0-202-264.2-520.6
-104.2
-180.7
-124.7
-93.6
-65
448.4
-52.8
-80
56.2
-41.1
-216.1
69.1
-81.5
-37.4
-97.3
-39.3
345.5
-20
35.8

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0826.4591.4-78.3
-523.4
151.1
533.7
-227.9
196.4
267.4
18.8
24.3
29.3
-155.4
96.3
-328.9
109.9
-3.4
-3.6
26.9
306.2
-1.5
-20.3

cash-flows.row.cash-at-end-of-period

01928.31101.9510.5
588.8
1112.3
961.2
427.4
655.4
458.9
191.5
172.8
148.5
119.2
274.6
178.4
507.2
397.4
400.8
404.3
377.5
71.3
72.9

cash-flows.row.cash-at-beginning-of-period

01101.9510.5588.8
1112.3
961.2
427.4
655.4
458.9
191.5
172.8
148.5
119.2
274.6
178.4
507.2
397.4
400.8
404.3
377.5
71.3
72.9
93.2

cash-flows.row.operating-cash-flow

0443.1733.5485.6
542.4
155.5
383.5
283.5
140.9
67.5
183.3
137.6
197.8
22.6
39.1
73.5
37.2
79.3
120.1
76.5
18.5
51
6.1

cash-flows.row.capital-expenditure

0-44-34.4-71.9
-97.2
-40.6
-46.4
-57.3
-81.5
-84.5
-66
-84.3
-256.3
-63.9
-58.4
-123.3
-95.3
-22.5
-21.4
-16.7
-56.5
-34
-59.2

cash-flows.row.free-cash-flow

0399.1699413.7
445.1
114.9
337.1
226.2
59.4
-17
117.4
53.4
-58.4
-41.3
-19.3
-49.8
-58.1
56.7
98.7
59.8
-38
16.9
-53.2

Tuloslaskelmarivi

ZhuZhou QianJin Pharmaceutical Co.,Ltd liikevaihto muuttui NaN% edelliseen kauteen verrattuna. 600479.SS:n bruttovoitto ilmoitetaan NaN. Yrityksen toimintakulut ovat NaN, ja niissä on tapahtunut NaN%:n muutos edelliseen vuoteen verrattuna. Poistojen ja arvonalentumisten kulut ovat NaN, mikä on NaN% muutos edellisestä tilikaudesta. Toimintakulujen ilmoitetaan olevan NaN, mikä osoittaa NaN%:n muutoksen edellisvuoteen verrattuna. Myynti- ja markkinointikulut ovat NaN, mikä on NaN% muutos edelliseen vuoteen verrattuna. Viimeisimpiin lukuihin perustuva käyttökate on NaN, mikä vastaa NaN%:n kasvua edellisvuoteen verrattuna. Liikevoitto on NaN, joka osoittaa NaN%:n muutosta edelliseen vuoteen verrattuna. Nettotuloksen muutos on NaN%. Viime vuoden nettotulos oli NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

income-statement-row.row.total-revenue

03798.54026.33663.8
3627
3525.2
3328.6
3182.7
2864.9
2446.7
2194.2
1972.9
1583.4
1256.5
979.4
904.3
801.4
679.8
602.7
665.8
604.9
686.8
582
560.2

income-statement-row.row.cost-of-revenue

02046.72289.92032.2
2030.8
1918.7
1776.3
1743.2
1573.3
1311.5
1141.1
1006.8
786.3
603.5
427.9
360.8
345.8
322.3
309.4
423.8
409.4
476.1
405.9
417.3

income-statement-row.row.gross-profit

01751.81736.41631.6
1596.2
1606.5
1552.3
1439.5
1291.6
1135.2
1053.1
966
797.1
653
551.6
543.4
455.6
357.5
293.3
242
195.5
210.7
176.1
142.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-3337.9218.6189.1
156.1
147.8
14.9
-9.7
13.6
15
10.5
3.7
0.7
1.6
8.1
1.7
-1.1
0.1
1.2
1.3
1.8
-0.8
-0.9
-2

income-statement-row.row.operating-expenses

03337.91311.71261.1
1224.8
1247.8
1249.1
1170.9
1111.7
1042.9
924.3
810.4
663.7
536.5
474
404.5
345.3
282.9
237.7
178
146.3
142.3
118.1
92.9

income-statement-row.row.cost-and-expenses

03337.93601.53293.4
3255.6
3166.5
3025.4
2914.1
2685
2354.4
2065.4
1817.2
1450
1140.1
901.8
765.3
691
605.2
547.1
601.8
555.7
618.4
524
510.1

income-statement-row.row.interest-income

051.49.811.9
30.4
38.6
20.9
11.7
10.9
4.6
1.2
0.2
1.7
4.1
1.6
0
0
0
2.4
1.8
3.7
1.9
1.6
1.7

income-statement-row.row.interest-expense

01.72.22.1
2.2
0.4
0.7
2.6
2.8
6.5
6.1
4.1
2.1
0.2
0.1
-1
-1.9
0.7
1.1
0.1
1.2
2.3
1.1
0.3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1.51.6-2.8
0.4
-1.1
49.1
18
26.5
17.3
11.6
-2.8
17.9
-6.8
31.9
17.1
31.4
123.3
27.9
9.1
6.5
1.2
1.3
-0.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-3337.9218.6189.1
156.1
147.8
14.9
-9.7
13.6
15
10.5
3.7
0.7
1.6
8.1
1.7
-1.1
0.1
1.2
1.3
1.8
-0.8
-0.9
-2

income-statement-row.row.total-operating-expenses

0-1.51.6-2.8
0.4
-1.1
49.1
18
26.5
17.3
11.6
-2.8
17.9
-6.8
31.9
17.1
31.4
123.3
27.9
9.1
6.5
1.2
1.3
-0.5

income-statement-row.row.interest-expense

01.72.22.1
2.2
0.4
0.7
2.6
2.8
6.5
6.1
4.1
2.1
0.2
0.1
-1
-1.9
0.7
1.1
0.1
1.2
2.3
1.1
0.3

income-statement-row.row.depreciation-and-amortization

0103.7104.247.3
60.3
40.8
61.8
62.7
50.2
50.4
48.5
48.3
40
38.3
36
25.2
21.8
20.9
24.3
23.3
22
18.3
13.1
-1.9

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0460.6444.2436.2
424.2
430.8
337.4
296.3
194
94.8
130.4
150
150.9
108.1
101.5
155.2
143.1
198.9
83.9
74.3
55.3
71.5
60.2
51.9

income-statement-row.row.income-before-tax

0459.1445.8433.4
424.6
429.7
352.3
286.6
206.4
109.6
140.4
152.8
151.3
109.7
109.5
156.1
141.8
197.9
84.3
74.3
56.4
70.1
59.3
49.7

income-statement-row.row.income-tax-expense

065.457.658.7
64.4
77.6
49.7
40
33
21.3
22.7
24.1
20.4
14.9
12
19.1
7.3
21.3
9.4
12.6
9.8
21.7
20.3
14.4

income-statement-row.row.net-income

0320.4302.5302.1
297.1
294.3
255.4
207.8
149.4
93
105.1
123.8
120.2
82.8
86.4
130.9
129.9
173.6
71.8
59.9
45.4
50.1
39.8
34.5
Samanlaisia osakkeita
Saatat olla myös kiinnostunut:
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
WOCKPHARMA.BO
Wockhardt Limited.
532.5 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

Usein kysytty kysymys

Mikä on ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) taseen loppusumma?

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) kokonaisvarat ovat 4676882466.000.

Mikä on yrityksen vuotuinen liikevaihto?

Vuotuinen liikevaihto on N/A.

Mikä on yrityksen voittomarginaali?

Yrityksen voittomarginaali on 0.465.

Mikä on yrityksen vapaa kassavirta?

Vapaa kassavirta on 1.021.

Mikä on yrityksen nettovoittomarginaali?

Nettovoittomarginaali on 0.073.

Mikä on yrityksen kokonaistulot?

Kokonaisliikevaihto on 0.121.

Mikä on ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) nettovoitto (nettotulos)?

Nettovoitto (nettotulos) on 320405834.000.

Mikä on yrityksen kokonaisvelka?

Kokonaisvelka on 116705915.000.

Mikä on yrityksen toimintakulujen määrä?

Toimintakulut ovat 3337921320.000.

Mikä on yrityksen kassan määrä?

Yrityksen kassavarat ovat 0.000.